inTEST Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor (“semi”), today announced the launch of its Electronic Test Division’s latest innovation for electric vehicle (EV) battery testing technology. The Acculogic patent-pending hover sense non-contact technology represents a significant leap forward in validating the quality and reliability of EV battery interconnects. EVs rely heavily on the efficiency and dependability of their battery systems. The systems include numerous cell interconnects that are critical to the battery’s overall performance and affect everything from power output to charge times.
HC Wainwright & Co. Reiterates Buy on Inozyme Pharma, Maintains $20 Price Target
HC Wainwright & Co. analyst Edward White reiterates Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $20 price target.
